Menu
Kevin Matthews was a key figure in both the 2018 campaign to decriminalize psilocybin in Denver and the 2022 campaign to pass Prop 122, which legalized psychedelics in regulated and personal use settings. Today he is CEO of the Helix Consulting Group, a public affairs and education services firm for the psychedelic ecosystem. Matthews recently […]
A Q&A with Alchemy’s Deidra Somerville Deidra Somerville is the executive director of the Alchemy Community Therapy Center, a nonprofit psychedelic-therapy clinic that treats underserved populations in Oakland, California. HealingMaps named it one of the best ketamine clinics in the region for striving to create “a world where everyone can access the freeing mental health […]
A Q&A with Sheva Pekar A long-time advocate of policy reform in both cannabis and psychedelics, Sheva Pekar was one of the driving forces behind Denver’s decriminalization of psilocybin in 2019. Today, her consultancy firm PsyCann Advisors works with businesses around the country to navigate the varying legal landscapes of these emerging markets. Pekar recently […]
A Q&A with Oregon’s Angela Allbee Angela Allbee is manager of the Oregon Psilocybin Services Section, which is part of the Public Health Division of the Oregon Health Authority, and oversees the implementation of Measure 109. In January, her team began accepting license applications from aspiring psilocybin facilitators, manufacturers, service centers and testing labs. A […]
Taylor West served as chief of staff for New Approach, a PAC that campaigned for Oregon’s Measure 109 and Colorado’s Prop 122, both successful ballot initiatives that made psychedelic therapies legal in those states. A veteran in drug policy reform with more than two decades of experience in project leadership and strategic communications, she has […]
